Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUCYNA: Mifepristone for Cervical Ripening at Full-Term Pregnancy
2019-002032-84Phase 2Terminated
- Sponsor
- Disphar
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Pregnancy prolongation comparing Mifepristone 150 mg with Placebo (2 arms). Primary endpoint: Gain in Bishop score at 48 hours from baseline. Started Jun 2019; status: terminated.
02
Drugs
mifepristone
03
Conditions
Pregnancy prolongation
Beyond the preview
Go deeper on 2019-002032-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002032-84.